Plant ID: NPO19367
Plant Latin Name: Thespesia populnea
Taxonomy Genus: Thespesia
Taxonomy Family: Malvaceae
NCBI TaxonomyDB:
3638
Plant-of-the-World-Online:
564713-1
Bangladesh; Liberia; Sudan; Guinea; Cambodia; Bahamas; Netherlands; Somalia; Vanuatu; Nigeria; Cameroon; Burkina Faso; Benin; Ghana; Cuba; Venezuela; Cape Verde; Togo; China; Oman; Haiti; Belize; Tanzania; Eritrea; Maldives; Gambia; Philippines; New Caledonia; Mauritius; Trinidad and Tobago; Vietnam; Dominican Republic; Jamaica; Seychelles; Honduras; Mexico; India; Senegal; Mozambique; Colombia; Sri Lanka; Kenya; Taiwan; Fiji
GAA; | |
BCL2; BCL2L1; | |
ESR1; | |
ALOX15; HSD17B10; LDHA; LDHB; ALOX12; AKR1B1; POLB; | |
KDM4E; | |
HIF1A; | |
SLCO1B3; SLCO1B1; | |
MCL1; MPG; LMNA; |
Cytochrome P450 Enzymes: | CYP2C19; |
---|
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2C19 | Cytochrome P450 2C19 | P33261 | CHEMBL3622 |
Enzyme_unclassified | ALOX15 | Arachidonate 15-lipoxygenase | P16050 | CHEMBL2903 |
Enzyme_unclassified | HSD17B10 | Endoplasmic reticulum-associated amyloid beta-peptide-binding protein | Q99714 | CHEMBL4159 |
Enzyme_unclassified | LDHA | L-lactate dehydrogenase A chain | P00338 | CHEMBL4835 |
Enzyme_unclassified | LDHB | L-lactate dehydrogenase B chain | P07195 | CHEMBL4940 |
Enzyme_unclassified | ALOX12 | Arachidonate 12-lipoxygenase | P18054 | CHEMBL3687 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Enzyme_unclassified | POLB | DNA polymerase beta | P06746 | CHEMBL2392 |
Hydrolase | GAA | Lysosomal alpha-glucosidase | P10253 | CHEMBL2608 |
Lysine demethylase | KDM4E | Lysine-specific demethylase 4D-like | B2RXH2 | CHEMBL1293226 |
Miscellaneous ion channel | BCL2 | Apoptosis regulator Bcl-2 | P10415 | CHEMBL4860 |
Miscellaneous ion channel | BCL2L1 | Apoptosis regulator Bcl-X | Q07817 | CHEMBL4625 |
Nuclear hormone receptor subfamily 3 group A | ESR1 | Estrogen receptor alpha | P03372 | CHEMBL206 |
SLC superfamily of solute carriers | SLCO1B3 | Solute carrier organic anion transporter family member 1B3 | Q9NPD5 | CHEMBL1743121 |
SLC superfamily of solute carriers | SLCO1B1 | Solute carrier organic anion transporter family member 1B1 | Q9Y6L6 | CHEMBL1697668 |
Transcription Factor | HIF1A | Hypoxia-inducible factor 1 alpha | Q16665 | CHEMBL4261 |
Unclassified | MCL1 | Induced myeloid leukemia cell differentiation protein Mcl-1 | Q07820 | CHEMBL4361 |
Unclassified | MPG | DNA-3-methyladenine glycosylase | P29372 | CHEMBL3396943 |
Unclassified | LMNA | Prelamin-A/C | P02545 | CHEMBL1293235 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0005488; binding | GO:0051434; BH3 domain binding | 8.058E-09 | 1.755E-04 | BCL2, BCL2L1, MCL1 |
BP | GO:0008152; metabolic process | GO:0055114; oxidation-reduction process | 5.911E-08 | 4.198E-04 | AKR1B1, ALOX12, ALOX15, CYP2C19, GAA, HSD17B10, KDM4E, LDHA, LDHB |
BP | GO:0008152; metabolic process | GO:0006089; lactate metabolic process | 1.325E-07 | 4.808E-04 | HIF1A, LDHA, LDHB |
BP | GO:0009987; cellular process | GO:0008630; intrinsic apoptotic signaling pathway in response to DNA damage | 5.231E-07 | 1.424E-03 | BCL2, BCL2L1, MCL1, POLB |
BP | GO:0008152; metabolic process | GO:2001303; lipoxin A4 biosynthetic process | 9.167E-07 | 1.663E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0047977; hepoxilin-epoxide hydrolase activity | 9.167E-07 | 1.663E-03 | ALOX12, ALOX15 |
BP | GO:0009987; cellular process | GO:2001243; negative regulation of intrinsic apoptotic signaling pathway | 2.011E-06 | 3.128E-03 | BCL2, BCL2L1, HIF1A, MCL1 |
MF | GO:0003824; catalytic activity | GO:0004052; arachidonate 12-lipoxygenase activity | 2.748E-06 | 3.559E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0051120; hepoxilin A3 synthase activity | 2.748E-06 | 3.559E-03 | ALOX12, ALOX15 |
BP | GO:0009987; cellular process | GO:2001240; negative regulation of extrinsic apoptotic signaling pathway in absence of ligand | 4.736E-06 | 4.465E-03 | BCL2, BCL2L1, MCL1 |
BP | GO:0008152; metabolic process | GO:0051122; hepoxilin biosynthetic process | 9.151E-06 | 6.227E-03 | ALOX12, ALOX15 |
MF | GO:0003824; catalytic activity | GO:0004459; L-lactate dehydrogenase activity | 9.151E-06 | 6.227E-03 | LDHA, LDHB |
CC | GO:0032991; macromolecular complex | GO:0097136; Bcl-2 family protein complex | 1.372E-05 | 7.297E-03 | BCL2L1, MCL1 |
BP | GO:0008152; metabolic process | GO:0019369; arachidonic acid metabolic process | 1.939E-05 | 8.983E-03 | ALOX12, ALOX15, CYP2C19 |
BP | GO:0050896; response to stimulus | GO:0010332; response to gamma radiation | 1.939E-05 | 8.983E-03 | BCL2, BCL2L1, POLB |
BP | GO:0009987; cellular process | GO:2001244; positive regulation of intrinsic apoptotic signaling pathway | 2.164E-05 | 9.425E-03 | BCL2, BCL2L1, MCL1 |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 8.661E-06 | 2.685E-04 | LDHB, LDHA, GAA, ALOX15, AKR1B1, ALOX12, CYP2C19, HSD17B10 |
09140 Cellular Processes | 09143 Cell growth and death | hsa04210 | Apoptosis | 8.216E-06 | 2.685E-04 | LMNA, BCL2, BCL2L1, MCL1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00590 | Arachidonic acid metabolism | 2.653E-05 | 5.484E-04 | ALOX15, ALOX12, CYP2C19 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04066 | HIF-1 signaling pathway | 1.211E-04 | 1.876E-03 | LDHA, BCL2, HIF1A |
09150 Organismal Systems | 09156 Nervous system | hsa04726 | Serotonergic synapse | 1.552E-04 | 1.924E-03 | ALOX15, ALOX12, CYP2C19 |
09130 Environmental Information Processing | 09132 Signal transduction | hsa04630 | Jak-STAT signaling pathway | 4.271E-04 | 2.750E-03 | BCL2, BCL2L1, MCL1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00591 | Linoleic acid metabolism | 3.419E-04 | 2.750E-03 | ALOX15, CYP2C19 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00640 | Propanoate metabolism | 4.170E-04 | 2.750E-03 | LDHB, LDHA |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 3.661E-04 | 2.750E-03 | GAA, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00620 | Pyruvate metabolism | 6.527E-04 | 3.679E-03 | LDHB, LDHA |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00010 | Glycolysis / Gluconeogenesis | 1.822E-03 | 7.532E-03 | LDHB, LDHA |
09100 Metabolism | 09105 Amino acid metabolism | hsa00270 | Cysteine and methionine metabolism | 8.261E-04 | 4.268E-03 | LDHB, LDHA |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05014 | Amyotrophic lateral sclerosis (ALS) | 1.060E-03 | 5.057E-03 | BCL2, BCL2L1 |
09160 Human Diseases | 09161 Cancers | hsa05230 | Central carbon metabolism in cancer | 1.822E-03 | 7.532E-03 | LDHA, HIF1A |
09120 Genetic Information Processing | 09124 Replication and repair | hsa03410 | Base excision repair | 4.436E-04 | 2.750E-03 | POLB, MPG |
09150 Organismal Systems | 09154 Digestive system | hsa04976 | Bile secretion | 2.043E-03 | 7.918E-03 | SLCO1B1, SLCO1B3 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
C00-D49: Neoplasms | Chronic lymphocytic leukaemia | C91 | BCL2; |
C00-D49: Neoplasms | Advanced melanoma | C43 | BCL2; |
C00-D49: Neoplasms | Relapsed or refractory chronic lymphocytic leukemia | NA | BCL2L1; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | AKR1B1; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | BCL2L1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | AKR1B1; |
C00-D49: Neoplasms | Multiple myeloma | C90 | BCL2; |
G00-G99: Diseases of the nervous system G00-G99 | Amyotrophic lateral sclerosis | G12.2 | BCL2; |
L00-L99: Diseases of the skin and subcutaneous tissue | Psoriasis | L40 | BCL2; |
C00-D49: Neoplasms | Prostate cancer | C61 | BCL2; |
NA: NA | Lymphoid malignancies | NA | BCL2L1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | AKR1B1; |
C00-D49: Neoplasms | Breast cancer | C50 | BCL2; |
C00-D49: Neoplasms | Advanced small cell lung cancer | NA | BCL2L1; |
C00-D49: Neoplasms | Cancer | C00-C96 | BCL2L1; BCL2; |
C00-D49: Neoplasms | Leukemia | C90-C95 | BCL2; |
C00-D49: Neoplasms | Lymphoma | C81-C86 | BCL2; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | AKR1B1; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Gout | M10 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic complication | E08-E13 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic cataract | E10.36, E11.36 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic neuropathy | E11.40 | AKR1B1; |